hypertensive patients from central and eastern European countries: results of the BP-CARE study. European Heart Journal, 32(2), 218-225. • Jasjukevitš, T. (2016). Raviresistentne hüpertensioon. Perearst, 3(112), 45-53. • Kingisepp, P.-H. (2006). Inimese füsioloogia. Tartu: AS Atlex. • Lätt, K. (2015). Hüpertensioon: ravida tuleb patsiendi, mitte numbreid. Perearst, 3(101), 21-28. • Nilsson, P., Journath, G., Palm, K., Viigimaa, M. (2007). Risk factor control in treated hypertensives from Estonia and Sweden. Why the difference? Blood Press, 16(5), 301-304. • Uuetoa, T., Martinson, K., Rebane, M., Keerd, A., (2015). Täiskasvanute kõrgvererõhutõve patsiendijuhend. TÄNAME TÄHELEPANU EEST!
432 Chapter 24 Bioactive peptides generated from food physiological functions in our body, beyond proteins, such as milk and soy proteins, have adequate nutritional effects, in a way that is been utilized for functional ingredients. For relevant to either an improved state of health example, several food products containing and well-being or a reduction of the risk of ACE inhibitory peptides have been marketed disease. for hypertensives (Arihara 2006b). Although Probiotic bacteria, mainly intestinal bioactive peptides have not yet been utilized Lactobacillus and Bifidobacterium, show in the meat industry, such peptides are prom- various physiological functions, such as ising candidates for ingredients of functional modulation of intestinal flora, prevention of meat products. Also, bioactive peptides gen- diarrhea, improvement of constipation, low-
annaabi.ee 
